Showing results (211-220 of 299) with videos related to
Sort By:
Pageof 30
Thoracic Cancer|December 9, 2021
Multicenter real-world data of patients harboring rare mutations other than EGFR or ALK in advanced or metastatic non-small cell lung cancerSu Yeon Lee, Young Chul Kim, Kye Young Lee, et al.BMC Pulmonary Medicine|May 17, 2024
A prospective, open-label, randomized clinical trial to evaluate the efficacy and safety of remimazolam in patients undergoing EBUS-TBNA: REST trial designHee Yun Seol, Kyung Soo Hong, Jong Geol Jang, et al.Clinical Chemistry and Laboratory Medicine|September 9, 2011
Direct sequencing in cytological specimens as a useful strategy for detecting EGFR mutations in non-small cell lung cancer patientsMin-Chul Cho, Chang-Min Choi, Sollip Kim, et al.Thoracic Cancer|December 24, 2021
Preoperative electromagnetic navigation bronchoscopy-guided one-stage multiple-dye localization for resection of subsolid nodules: A single-center pilot studyJong Hwan Jeong, Hyeongbin Park, Chang-Min Choi, et al.Journal of Korean Medical Science|August 7, 2023
Cancer-Related Dysfunctional Beliefs About Sleep Mediate the Influence of Sleep Disturbance on Fear of Progression Among Patients With Surgically Resected Lung CancerHarin Kim, Wonjun Ji, Jong Won Lee, et al.Lung Cancer (Amsterdam, Netherlands)|December 2, 2011
Clinicopathologic implication of ALK rearrangement in surgically resected lung cancer: a proposal of diagnostic algorithm for ALK-rearranged adenocarcinomaJin Ho Paik, Chang-Min Choi, Hyojin Kim, et al.Thoracic Cancer|October 19, 2022
A phase II, multicenter study of lazertinib as consolidation therapy in patients with locally advanced, unresectable, EGFR mutation-positive non-small cell lung cancer (stage III) who have not progressed following definitive, platinum-based, chemoradiation therapy (PLATINUM trial)Juwhan Choi, Jeong Eun Lee, Chang-Min Choi, et al.Cancer Research and Treatment|January 16, 2024
Contribution of Enhanced Locoregional Control to Improved Overall Survival with Consolidative Durvalumab after Concurrent Chemoradiotherapy in Locally Advanced Non-Small Cell Lung Cancer: Insights from Real-World DataJeong Yun Jang, Si Yeol Song, Young Seob Shin, et al.Cancer Research|October 30, 2013
MET and AXL inhibitor NPS-1034 exerts efficacy against lung cancer cells resistant to EGFR kinase inhibitors because of MET or AXL activationJin Kyung Rho, Yun Jung Choi, Seon Ye Kim, et al.BMC Cancer|December 28, 2013
Mechanisms of acquired resistance to EGFR-tyrosine kinase inhibitor in Korean patients with lung cancerWonjun Ji, Chang-Min Choi, Jin Kyung Rho, et al.Pageof 30